• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

25.35 -1.07 (-4.05%)
Delayed Quote Updated: 2:09 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60,108
Open 26.24
Bid (Size) 25.10 (1,500)
Ask (Size) 25.60 (100)
Prev. Close 26.42
Today's Range 25.10 - 26.50
52wk Range 5.260 - 31.97
Shares Outstanding 78,614,114
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
September 24, 2026
Biodesix-led tumor-informed and tumor-naïve programs draw on the company’s bioinformatics and diagnostics test development expertise 
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
September 14, 2026
Industry-leading QA/RA excellence accelerates patient access to Biodesix Lab testing, which helps improve overall outcomes for patients with lung nodules 
From Biodesix, Inc.
Via GlobeNewswire

Performance

52-Week Range 20.7% below 52-week high
25.35
5.2652W Low 31.9752W High
1 Week 15.5% below 1-week high
26.071W Low 30.001W High

Biodesix, Inc. - Common Stock (BDSX) traded between $5.26 and $31.97 over the past 52 weeks and last traded at $25.35, 20.7% below its 52-week high. Over the past week it ranged between $26.07 and $30.00.

Past 12 Months
-7.2%
-4.8%
+25.8%
+77.9%
+292.4%
+247.3%
1W -$1.98
1M -$1.28
3M +$5.20
6M +$11.10
YTD +$18.89
1Y +$18.05

BDSX was +247.3% over the past year, +77.9% over six months, +292.4% year to date, -7.2% in the last week.

12 Months vs Market
BDSX
+247.3%
DIA
+9.6%
SPY
+15.4%
QQQ
+23.4%
IWM
+13.6%

Over the past 12 months BDSX returned +247.3% versus DIA (Dow) +9.6%, SPY (S&P 500) +15.4%, QQQ (Nasdaq 100) +23.4% and IWM (Russell 2000) +13.6%.

Volume & Liquidity 0.60× 3-mo avg
Today 60,108 3-mo avg 100.9K
1W
128.8K
1M
101.2K
3M
100.9K
6M
87.8K
YTD
525.4K
1Y
434.9K

BDSX most recently traded 60,108 shares against a 3-month average daily volume of 100.9K.

More News

Read More
News headline image
Biodesix to Participate in Upcoming Investor Conferences
September 03, 2026
From Biodesix, Inc.
Via GlobeNewswire
BioDesix (NASDAQ:BDSX) Passes Minervini Trend Template but Setup Quality Remains Weak ↗
September 02, 2026
Via Chartmill
Biodesix (NASDAQ:BDSX) Q2 EPS Beats, Revenue In Line, Shares Slip ↗
August 05, 2026
Via Chartmill
Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance ↗
May 04, 2026
Via Chartmill
Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability ↗
February 26, 2026
Via Chartmill
Topics Earnings
News headline image
Biodesix (BDSX) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Via The Motley Fool
Topics Earnings
News headline image
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference ↗
August 12, 2026
Via MarketBeat
News headline image
Biodesix Q2 Earnings Call Highlights ↗
August 05, 2026
Via MarketBeat
Topics Earnings
News headline image
Biodesix Announces Second Quarter 2026 Results and Highlights
August 05, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
August 04, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Upcoming Investor Conferences
May 21, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
May 11, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix (BDSX) Q1 2026 Earnings Transcript ↗
May 04, 2026
Via The Motley Fool
News headline image
Biodesix BDSX Q2 2025 Earnings Call Transcript ↗
May 04, 2026
Via The Motley Fool
Topics Earnings
News headline image
Biodesix Announces First Quarter 2026 Results and Highlights
May 04, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
April 20, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Recognized as a Top Workplace for Third Consecutive Year
April 09, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
April 06, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
March 20, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix (BDSX) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
News headline image
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
February 26, 2026
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Upcoming Investor Conferences
February 24, 2026
From Biodesix, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Biodesix, Inc. - Common Stock publicly traded?
Yes, Biodesix, Inc. - Common Stock is publicly traded.
What exchange does Biodesix, Inc. - Common Stock trade on?
Biodesix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Biodesix, Inc. - Common Stock?
The ticker symbol for Biodesix, Inc. - Common Stock is BDSX on the Nasdaq Stock Market
What is the current price of Biodesix, Inc. - Common Stock?
The current price of Biodesix, Inc. - Common Stock is 25.35
When was Biodesix, Inc. - Common Stock last traded?
The last trade of Biodesix, Inc. - Common Stock was at 10/08/26 02:09 PM ET
What is the market capitalization of Biodesix, Inc. - Common Stock?
The market capitalization of Biodesix, Inc. - Common Stock is 1.99B
How many shares of Biodesix, Inc. - Common Stock are outstanding?
Biodesix, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap